COUR PHARMACEUTICALS DEVELOPMENT
Cour Pharmaceuticals Development Co Inc operates in the pharmaceutical sector. Cour Pharmaceuticals Development Co Inc was founded in 2012 and is based in Elmhurst, Illinois.
COUR PHARMACEUTICALS DEVELOPMENT
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Skokie, Illinois, United States
Country:
United States
Website Url:
http://www.courpharma.com
Total Employee:
11+
Status:
Active
Contact:
8885512687
Email Addresses:
[email protected]
Total Funding:
30.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Investors List
Alpha Wave Ventures
Alpha Wave Ventures investment in Venture Round - Cour Pharmaceuticals Development
Official Site Inspections
http://www.courpharma.com
- Host name: 23.249.1.30
- IP address: 23.249.1.30
- Location: Rancho Cordova United States
- Latitude: 38.6106
- Longitude: -121.2789
- Metro Code: 862
- Timezone: America/Los_Angeles
- Postal: 95670
More informations about "Cour Pharmaceuticals Development"
Our Company - COUR Pharmaceuticals
This approach does not address the underlying cause of immune-related disease. Scientists in immunology have posited that the gold standard for treating …See details»
Board of Directors - COUR Pharmaceuticals
Tim Walbert. Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, AmgenSee details»
Cour Pharmaceuticals Development Co., Inc. | LinkedIn
Cour Pharmaceuticals Development Co., Inc. Pharmaceutical Manufacturing Skokie, Illinois 5,259 followers First-in-class therapies designed to reprogram the immune systemSee details»
Cour Pharmaceuticals Development - Crunchbase
Organization. Cour Pharmaceuticals Development . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»
After 10 Years of Hard Work, COUR Treads Into …
Feb 18, 2025 “There’s nothing we can do to affect the macro environment around it, but our job, really, within COUR is to make sure that we’re ready and that we’re going to continue to create value for the company and for patients,” …See details»
Cour Pharma - 2025 Company Profile - Tracxn
Mar 26, 2025 Cour Pharma has raised a total funding of $135M over 6 rounds. Its first funding round was on Jan 28, 2013. Its latest funding round was a Series A round on Jan 30, 2024 for …See details»
Cour Pharmaceuticals - LifeScienceHistory.com
Courpharma.com. 8025 Lamon Ave. Skokie, IL 60077. Company Info Year Established 2012. Contacts John J. Puisis Founder & CEO Dannielle Appelhans COO Brian Bock CFO Roy First, …See details»
COUR Pharmaceuticals Announces Leadership Transition for
Aug 1, 2024 Founder John J. Puisis to transition CEO role to current COO Dannielle Appelhans. Mr. Puisis to remain on COUR Board of Directors. CHICAGO, Aug. 01, 2024 (GLOBE …See details»
Cour Pharmaceuticals Company Profile | Management and
Www.courpharma.com Cour Pharmaceuticals Profile and History COUR Pharmaceuticals is focused on developing first-in-class therapies designed to reprogram the immune system to …See details»
Cour Pharmaceuticals Development Co., Inc. (Cour …
Www.courpharma.com. 更新于：2025-03-06. ... Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, …See details»
COUR Pharmaceuticals Announces Leadership Transition for
Aug 1, 2024 Founder John J. Puisis to transition CEO role to current COO Dannielle Appelhans Mr. Puisis to remain on COUR Board of Directors CHICAGO, Aug. 01, 2024 ...See details»
Leadership - COUR Pharmaceuticals
Leadership. Bringing together extensive expertise in clinical development, scientific research, manufacturing and business, COUR’s leadership team embodies the company’s mission to …See details»
COUR Pharmaceuticals Announces Leadership Transition for …
Aug 1, 2024 Founder John J. Puisis to transition CEO role to current COO Dannielle Appelhans Mr. Puisis to remain on COUR Board of Directors CHICAGO, Aug. 01, 2024 (GLOBE …See details»
COUR Pharmaceuticals Secures $105 Million in Series A
Jan 30, 2024 For more information, please visit www.courpharma.com. About Lumira Ventures: Founded in 2007, Lumira Ventures is a multi-stage life sciences investment firm with offices in …See details»
Cour Pharmaceuticals - Overview, News & Similar companies
Feb 16, 2024 www.courpharma.com. Revenue <$5 Million. Industry Drug Manufacturing & Research Pharmaceuticals Healthcare . Recent News & Media. COUR Pharmaceuticals …See details»
COUR Pharmaceuticals Secures FDA Clearance of IND
CHICAGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed to …See details»
COUR Pharmaceuticals Enters Collaboration and Licensing
Dec 3, 2024 [email protected]. For Media Jason Braco [email protected]. Twitter; LinkedIn; Facebook; Email Print Illinois Alliances. Cour Pharmaceuticals Genentech, …See details»
Pharmaceutical Company Organizational Structure Guide
2 days ago A pharmaceutical company organization chart is a vital tool in helping all employees understand how the business works. A pharmaceutical company organizational structure …See details»
COUR Pharmaceuticals-COUR Pharmaceuticals Development …
查看医药魔方InvestGO®数据库COUR Pharmaceuticals的公司信息。COUR Pharmaceuticals（COUR Pharmaceuticals Development Company, Inc.），公司简介：COUR …See details»
COUR Pharmaceuticals Secures FDA Orphan Drug Designation
CHICAGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying...See details»